Our Chubby Cat – Living with Feline Diabetes

Our Chubby Cat – Living with Feline Diabetes

By Niki Waldron, Head of Formulation

Part of Jaguar’s staff contribution series

Diabetes is a chronic disease that occurs when the pancreas can’t make insulin or the body can’t utilize it effectively. Diabetes affects over 400 million people worldwide. In addition to affecting humans, diabetes also occurs in both dogs and cats. It is estimated that 1% of dogs and 1-2% of cats will develop diabetes.

For dogs, the risk of developing diabetes is higher for obese animals between 4 to 14 years of age.  Certain breeds also appear to be at a greater risk. Additionally, unspayed female dogs are twice as likely as male dogs to suffer from diabetes. For cats, risk factors again include obesity and age, with male cats more likely than females to develop the disease.

In general, diabetes symptoms for both dogs and cats are very similar: change in appetite, excessive thirst, increased urination, unexplained or rapid weight loss, sweet or fruity smelling breath and lethargy. For both dogs and cats, the disease can be managed through diet and insulin, and with an early diagnosis and properly administered therapy, the prognosis is good!

Our cat, Memma (pictured), was diagnosed with diabetes in February 2016. She had two of the most common predisposing conditions for cats—older and obese. Her most notable symptom was rapid weight loss, losing almost 5 pounds in about 6 weeks. While we were getting her stabilized, she also developed diabetic neuropathy which exhibited as very week hind legs, the inability to jump and walking on her hocks. Now that she is stabilized through her twice-daily insulin shots and prescription food, she is maintaining a good weight, has near normal blood glucose levels and her neuropathy has resolved.

November is National Pet Diabetes Month.

For more information:

World Health Organization, Diabetes

Cornell Feline Health Center, Feline Diabetes

Vetsulin, Merck Animal Health, Feline diabetes mellitus: Overview

Also published on Medium.

MYTESI® is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy (ART).

Important Safety Information about MYTESI®
MYTESI® is not indicated for the treatment of infectious diarrhea. Rule out infectious etiologies of diarrhea before starting MYTESI®.

If infectious etiologies are not considered, there is a risk that patients with infectious etiologies will not receive the appropriate therapy and their disease may worsen. In clinical studies, the most common adverse reactions occurring at a rate greater than placebo were upper respiratory tract infection (5.7%), bronchitis (3.9%), cough (3.5%), flatulence (3.1%), and increased bilirubin (3.1%).

Click to Read Full Prescribing Information